Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
AVBCC COVID-19 Webcast Series
Economics & Value
First National Study: Geographic Socioeconomic Disparities Mirror Substantial Gaps in Survival in Children with AML
Chase Doyle
Real-World Healthcare Utilization and Costs Support Broader Use of CAR T-Cell Therapy
Phoebe Starr
Value-Based Care Management Medicare Program Changes for 2020 and Beyond
Joseph S. Bailes, MD
,
Gena Cook
View More Articles
Personalized Medicine
Loss of Y Chromosome in Men Makes Bladder Cancer More Aggressive
Nadia Jaber
Liquid Biopsies on the Horizon for Children With Solid Cancers
Ella Ben-Ari
Recent Developments in Genomic-Driven Therapies for Cholangiocarcinoma
View More Articles
Value in Oncology
NCCN Panel Debates Cancer Care in Value-Based Healthcare Models
Wayne Kuznar
FDA Implements New Steps to Encourage Generic Drug Competition, Expand Patients’ Access to Inexpensive Medicines
Eileen Koutnik-Fotopoulos
Rapid Adoption of Oncology Drugs Improves Survival
Chase Doyle
View More Articles
FDA Approvals, News & Updates
Fruzaqla FDA Approved for Relapsed Metastatic Colorectal Cancer
FDA Approved Loqtorzi, a PD-1 Inhibitor, for the Treatment of Metastatic or Recurrent Nasopharyngeal Carcinoma
Keytruda Plus Chemotherapy Receives New FDA Approvals for Advanced Biliary Tract Cancer and 2 Forms of GEJ Adenocarcinoma
View More Articles
Emerging Therapies
Zanidatamab Demonstrates Efficacy in Refractory HER2-Amplified Biliary Tract Cancer
Investigational mRNA-Based Vaccine May Offer New Hope for Patients With High-Risk Melanoma
Phoebe Starr
First-Line Mosunetuzumab Safe and Effective in Older Patients with Diffuse Large B-Cell Lymphoma
Chase Doyle
View More Articles
Immunotherapy
Immunotherapy After Surgery Shows Long-Term Benefits for High-Risk Bladder Cancer
Sharon Reynolds
Personalized Vaccine plus Immune Checkpoint Inhibitor a Promising Approach to Cancer
Phoebe Starr
FDA Grants Priority Review to Keytruda for Patients with High-Risk, Non–Muscle-Invasive Bladder Cancer
Yvette Florio Lane
View More Articles
April 17, 2020: Revenue Cycle Management: COVID-19 Impact on Cancer Care and Road to Recovery
By
Brian Gockerman, MBA
;
Parag Shah
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
In this webcast, Brian Gockerman, Managing Director at Unlimited Systems, begins by discussing the stabilization of cancer care programs, the potential implications of telehealth, the decline of newly referred patients, and what to prepare for in the future. Parag Shah, President, Practice Solutions at Integra Connect, continues the conversation by discussing how to keep your team engaged when working remotely, the shift of solution providers and telehealth, payer challenges, and solutions to some of these issues.
Read Article
Welcoming Opening Remarks
By
Clifford Hudis, MD, FACP, FASCO
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
The Association for Value-Based Cancer Care (AVBCC) webcast was introduced by Dr Zweigenhaft, Founder of AVBCC, who assembled an exceptional group of experts from across the country to discuss the COVID-19 outbreak and its impact on the healthcare industry. After a few quick welcoming remarks to allow more time for the fast-moving presentations, Dr Zweigenhaft introduced Dr Hudis, who briefly presented ASCO’s outlook on the crisis.
Read Article
Washington and Public Policy: The COVID-19 Pandemic
By
Scott Gottlieb, MD
;
Jayson Slotnik, JD, MPH
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
Mr Slotnik opened the session with an inside look at Washington, addressing some of the changes to oncology care policies and operations from the COVID-19 pandemic. He outlined a quick overview of the initiatives from the Centers for Medicare & Medicaid Services (CMS), including new guidelines and the easing of some restrictions on physicians’ options for telemedicine.
Read Article
Community Care Providers and COVID-19
By
Lucio Gordan, MD
;
Ted Okon, MBA
;
Jeff Patton, MD
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
Up to 65% of cancer care is delivered via community cancer centers that are not part of a hospital or academic center. These centers are feeling the impact of COVID-19 as the pandemic reshapes the way these facilities provide care to patients.
Read Article
Comprehensive Cancer Care Systems
By
Pat Basu, MD, MBA
;
Robert W. Carlson, MD
;
Christian Downs, MHA, JD
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
According to the NCCN, an alliance of 30 leading academic cancer centers in the United States, the data suggest that although patients with cancer are not more susceptible to infection from the new coronavirus than other people, they do have much worse outcomes. “Prevention is thus the key for oncology patients,” Dr Carlson said.
Read Article
Wholesale Supply Channels Addressing the Pandemic
By
Barry Fortner, PhD
;
Tommy Pourmahram
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
Turning from the provision of care to the provision of therapies and essential personal protective equipment (PPE), Mr Pourmahram and Dr Fortner focused on the wholesale supply chain and the challenges of ensuring an uninterrupted flow of crucial materials to areas with the greatest demand.
Read Article
Managed Care Payers During the Pandemic
By
Scott Breidbart, MD, MBA
;
Matthew Eyles
;
Steven Peskin, MD, MBA, FACP
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
Dr Peskin, Dr Breidbart, and Mr Eyles gave an overview of the changes the novel coronavirus has prompted for managed care payers. They agreed that the unprecedented set of circumstances surrounding the pandemic has led to an opening of the floodgates to questions without immediate answers, leaving providers and payers in unfamiliar territory in a rapidly changing environment with few guideposts.
Read Article
Pharmaceutical Manufacturers’ Response to COVID-19
By
Eric Dozier
;
Julie Gerberding, MD
;
Brian Morrissey
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
The healthcare supply channel is dependent on drug manufacturers and their innovation and production. Representing 3 of the major biopharmaceutical companies, Dr Gerberding, Mr Morrissey, and Mr Dozier discussed the drug manufacturers’ response to the COVID-19 pandemic, announcing a recent collaboration in the fight against the novel coronavirus.
Read Article
Oncology Nursing and Cancer Care
By
Brenda Nevidjon, MSN, RN, FAAN
;
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
Oncology nurses and nurse navigators are positioned on the front lines of cancer care, playing an integral role in patients’ battles against cancer. Ms Shockney and Ms Nevidjon discussed the rapidly changing world that oncology nurses are facing because of COVID-19.
Read Article
Patient Advocacy During the Pandemic
By
Patricia J Goldsmith
;
Daniel J. Klein
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
Patient advocacy organizations regularly field and fulfill requests for assistance from patients with a serious illness, such as cancer. In the face of COVID-19, such requests have increased exponentially. Ms Goldsmith and Mr Klein outlined their organizations’ efforts to meet patients’ needs.
Read Article
Page 7 of 8
4
5
6
7
8
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Addressing Cancer Health Disparities: The No One Left Alone Initiative
Rohan Nathwani
,
Arva Patel
,
Warner Kornberg
,
Asutosh Gor, MD
,
Sashi Naidu, MD
,
Viral Rabara, MD
,
Niyati Nathwani, MD
,
Kashyap Patel, MD
2.
Navigating the Complex Landscape of Oral Cancer Medication
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma